PMDA drug package insert

アムロジピン錠2.5mg「ケミファ」

PMDA Prescription drug · 日本薬品工業株式会社 · package insert Oct 8, 2024

Key facts

Brand names アムロジピン錠2.5mg「ケミファ」, アムロジピン錠5mg「ケミファ」, アムロジピン錠10mg「ケミファ」, アムロジピンOD錠2.5mg「ケミファ」, アムロジピンOD錠5mg「ケミファ」, アムロジピンOD錠10mg「ケミファ」
Nonproprietary names アムロジピンベシル酸塩
Companies 製造販売元/日本薬品工業株式会社
Product type Prescription drug
Therapeutic category 高血圧症・狭心症治療薬; 持続性Ca拮抗薬
Therapeutic category codes 872171
YJ codes 2171022F1266, 2171022F2262, 2171022F5172, 2171022F3161, 2171022F4168, 2171022F6225
Approval numbers 22000AMX01025000, 22000AMX01026000, 22400AMX00995000, 22100AMX02032000, 22100AMX02033000, 22500AMX01655000
Package insert edition 第2版
Package insert date Oct 8, 2024
PMDA document key 530372_2171022F1266_1
PMDA company code 530372

At a glance

  • 1–9 Package insert revisions
  • 10–99 Related PMDA documents
  • None Safety communications
  • No PMDA review report published
  • No Risk management plan (RMP)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMDA approved drugs and package inserts (Japan)

Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date:

Browse all PMDA approved drugs and package inserts (Japan)